PCSK9 inhibitor alleviates experimental pulmonary fibrosis-induced pulmonary hypertension via attenuating epithelial-mesenchymal transition by suppressing Wnt/β-catenin signaling in vivo and in vitro

類似資料

• Increased serum albumin corrected anion gap levels are associated with poor prognosis in septic patients with liver cirrhosis
  著者:: Zetao Pan, 等
  出版事項: (2024-09-01)
• Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/β-catenin pathway
  著者:: Qian Lei, 等
  出版事項: (2022-09-01)
• PCSK9 inhibitors and osteoporosis: mendelian randomization and meta-analysis
  著者:: Ding-Qiang Chen, 等
  出版事項: (2024-07-01)
• Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway
  著者:: Xiaomin Tang, 等
  出版事項: (2019-07-01)
• FERMT3 mediates cigarette smoke-induced epithelial–mesenchymal transition through Wnt/β-catenin signaling
  著者:: Xiaoshan Su, 等
  出版事項: (2021-11-01)